Terns Pharmaceuticals Shares Are Trading Lower After the Company Announced It Priced a $150.1 Million Public Offering of 11,919,048 Shares at $10.50 per Share.
Terns Pharmaceuticals Shares Are Trading Lower After the Company Announced It Priced a $150.1 Million Public Offering of 11,919,048 Shares at $10.50 per Share.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.